Oppenheimer (OPY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
13 Mar, 2026Executive summary
Annual Meeting scheduled for May 4, 2026, to be held virtually, with Class B voting stockholders eligible to vote on key corporate matters.
Matters include election of nine directors, ratification of auditors, advisory votes on executive compensation and its frequency, approval of amended Certificate of Incorporation, and other business.
Mr. A.G. Lowenthal controls 97.5% of Class B Stock and intends to vote in favor of all proposals, making approval of all matters highly likely.
Voting matters and shareholder proposals
Proposals: elect nine directors, ratify Deloitte & Touche LLP as auditors for 2026, approve executive compensation (say-on-pay), set frequency of say-on-pay vote (recommended every 3 years), approve Amended and Restated Certificate of Incorporation.
Board recommends voting FOR all directors, FOR auditor ratification, FOR executive compensation, FOR 3-year frequency, and FOR charter amendment.
Only Class B voting stockholders may vote; Class A non-voting stockholders may attend and submit questions but not vote.
Board of directors and corporate governance
Board consists of nine directors, seven of whom are independent; all directors attended 100% of meetings in 2025.
Committees: Audit, Compensation, Compliance, Nominating and Corporate Governance—all composed of independent directors.
Board leadership includes an independent Lead Director and regular executive sessions without management.
Succession planning is a key focus; CEO transition from A.G. Lowenthal to R.S. Lowenthal occurred in May 2025.
Annual board and committee self-evaluations and director education are conducted.
Latest events from Oppenheimer
- Annual meeting to vote on directors, auditors, executive pay, and charter changes, with all approvals expected.OPY
Proxy Filing2 Mar 2026 - Record 2024 results, leadership change, and all proposals approved amid market uncertainty.OPY
AGM 20253 Feb 2026 - Record 2025 earnings and revenue driven by robust Wealth Management and Capital Markets growth.OPY
Q4 202530 Jan 2026 - Annual meeting to elect directors, ratify auditors, and confirm CEO succession plan.OPY
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 13.7% to $424.4M; net income down 11.4% on higher compensation costs.OPY
Q3 20253 Nov 2025 - Net income surged 111% year-over-year on strong revenue, record AUM, and robust trading.OPY
Q2 20251 Aug 2025 - Net income jumped 76.8% on record AUM, revenue, and improved segment performance.OPY
Q3 202413 Jun 2025 - Earnings rebounded to $10.3M on 8% revenue growth and record AUM.OPY
Q2 202413 Jun 2025 - Net income up 17.7% to $30.7M; record equity and CEO transition signal future growth.OPY
Q1 20256 Jun 2025